Archive for the ‘Omega-3 fatty acids’ Category

The Effect of Supplementation with Omega-3 Polyunsaturated Fatty Acids on Markers of Oxidative Stress in Elderly Exposed to PM2.5

Tuesday, February 3rd, 2009

http://www.ehponline.org/docs/2008/10578/abstract.html

Environmental Health Perspectives Volume 116, Number 9, September 2008

Research

The Effect of Supplementation with Omega-3 Polyunsaturated Fatty Acids on Markers of Oxidative Stress in Elderly Exposed to PM2.5

Isabelle Romieu,1 Raquel Garcia-Esteban,2 Jordi Sunyer,2 Camilo Rios,3 Mireya Alcaraz-Zubeldia,3 Silvia Ruiz Velasco,4 and Fernando Holguin5

1Instituto Nacional de Salud Pública, Cuernavaca, Morelos, México; 2Instituto Municipal de Investigaciones Médicas and Centre de Recerca en Epidemiologia Ambiental, Barcelona, Spain; 3Instituto Nacional de Neurología, México DF, México; 4Instituto de Investigaciones en Matemáticas Aplicadas y en Sistemas, Universidad Nacional Autónoma de México, México DF, México; 5Emory University School of Medicine, Atlanta, Georgia, USA

Abstract
Background: The mechanisms of particulate matter (PM) -induced health effects are believed to involve inflammation and oxidative stress. Increased intake of omega-3 polyunsaturated fatty acids (n-3 PUFA) appears to have anti-inflammatory effects.

Objective: As part of a trial to evaluate whether n-3 PUFA supplementation could protect against the cardiac alterations linked to PM exposure, we measured biomarkers of response to oxidative stimuli [copper/zinc (Cu/Zn) superoxide dismutase (SOD) activity, lipoperoxidation (LPO) products, and reduced glutathione (GSH) ] and evaluated the impact of supplementation on plasma levels.

Methods: We recruited residents from a nursing home in Mexico City chronically exposed to PM 2.5 µm in aerodynamic diameter (PM2.5) and followed them from 26 September 2001 to 10 April 2002. We randomly assigned subjects in a double-blind fashion to receive either fish oil (n-3 PUFA) or soy oil. We measured PM2.5 levels indoors at the nursing home, and measured Cu/Zn SOD activity, LPO products, and GSH at different times during presupplementation and supplementation phases.

Results: Supplementation with either fish or soy oil was related to an increase of Cu/Zn SOD activity and an increase in GSH plasma levels, whereas exposure to indoor PM2.5 levels was related to a decrease in Cu/Zn SOD activity and GSH plasma levels.

Conclusion: Supplementation with n-3 PUFA appeared to modulate the adverse effects of PM2.5 on these biomarkers, particularly in the fish oil group. Supplementation with n-3 PUFA could modulate oxidative response to PM2.5 exposure.

Key words: biological markers, omega-3 polyunsaturated fatty acids (PUFA) , oxidative stress, PM 2.5. Environ Health Perspect 116:1237–1242 (2008) . doi:10.1289/ehp.10578 available via http://dx.doi.org/ [Online 16 May 2008]

Address correspondence to I. Romieu, Instituto Nacional de Salud Pública, Av. Universidad #655, Col. Santa Maria Ahuacatitlán, CP 62508, Cuernavaca, Morelos, México. Telephone: 52-777-101-29-35. Fax: 52-777-311-11-48. E-mail: iromieu@correo.insp.mx

Supplemental Material is available online at http://www.ehponline.org/members/2008/10578/suppl.pdf

We thank R. Nadif (INSERM U780, Villejuif, France) and P. Sly (University of Western Australia, Perth) , for their useful comments.

This work was supported by research grant 34483-M from the Mexican Consejo Nacional de Ciencia y Tecnología and by the Mexican Ministry of Health. I.R. was supported in part by the U.S. National Center for Environmental Health, Centers for Disease Control and Prevention (Atlanta, GA, USA) ; the GA2LEN project (European Union contract FOODCT-2004-506378) ; and the Spanish Ministry of Education and Science (SAB2004-0192) .

The authors declare they have no competing financial interests.

Received 20 June 2007 ; accepted 13 May 2008.

Correction

In Table 2 of the manuscript originally published online, the intercept for LPO was 34.54 ; it has been corrected here.

Omega3 Fatty acids for cardioprotection.

Wednesday, January 28th, 2009

Complete article free at
Mayo Clinic Proceedings

http://www.mayoclinicproceedings.com/inside.asp?AID=4637&UID=
Mayo Clin Proc. 2008 Mar;83(3):324-32. Links

Omega3 Fatty acids for cardioprotection.
Lee JH, O’Keefe JH, Lavie CJ, Marchioli R, Harris WS.

Address correspondence to James H. O’Keefe, MD, 4330 Wornall Rd, Ste 2000, Kansas City, MO 64111 (jhokeefe@cc-pc.com).

The most compelling evidence for the cardiovascular benefit provided by omega-3 fatty acids comes from 3 large controlled trials of 32,000 participants randomized to receive omega-3 fatty acid supplements containing docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) or to act as controls. These trials showed reductions in cardiovascular events of 19% to 45%. These findings suggest that intake of omega-3 fatty acids, whether from dietary sources or fish oil supplements, should be increased, especially in those with or at risk for coronary artery disease. Patients should consume both DHA and EPA. The target DHA and EPA consumption levels are about 1 g/d for those with known coronary artery disease and at least 500 mg/d for those without disease. Patients with hypertriglyceridemia benefit from treatment with 3 to 4 g/d of DHA and EPA, a dosage that lowers triglyceride levels by 20% to 50%. Although 2 meals of oily fish per week can provide 400 to 500 mg/d of DHA and EPA, secondary prevention patients and those with hypertriglyceridemia must use fish oil supplements if they are to reach 1 g/d and 3 to 4 g/d of DHA and EPA, respectively. Combination therapy with omega-3 fatty acids and a statin is a safe and effective way to improve lipid levels and cardiovascular prognosis beyond the benefits provided by statin therapy alone. Blood DHA and EPA levels could one day be used to identify patients with deficient levels and to individualize therapeutic recommendations.

PMID: 18316000 [PubMed - in process]